Clinical Trials
4
Active:1
Completed:1
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer
Phase 2
Active, not recruiting
- Conditions
- Pancreatic Cancer Non-resectable
- Interventions
- Procedure: Minimally Invasive Surgical Microwave Ablation (MIS-MWA)
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Baki Topal
- Target Recruit Count
- 12
- Registration Number
- NCT04156087
- Locations
- 🇧🇪
University Hospitals KU Leuven, Leuven, Vlaams-Brabant, Belgium
Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery
Withdrawn
- Conditions
- SurgeryBlood LossPeri-ampullary TumourPancreatic Tumour
- First Posted Date
- 2012-10-24
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Baki Topal
- Registration Number
- NCT01712971
- Locations
- 🇧🇪
University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
Phase 2
Terminated
- Conditions
- Peritoneal CarcinomatosisGastrointestinal Cancer
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Baki Topal
- Target Recruit Count
- 34
- Registration Number
- NCT01116791
- Locations
- 🇧🇪
University Hospitals Leuven, Leuven, Belgium
Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy
Phase 3
Completed
- Conditions
- Tumors
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2012-09-12
- Lead Sponsor
- Baki Topal
- Target Recruit Count
- 336
- Registration Number
- NCT00830778
- Locations
- 🇧🇪
University Hospital Gasthuisberg, Leuven, Belgium
News
No news found